CVRx, Inc. (CVRX) Earnings Call Analysis

NASDAQ · Healthcare · Medical Devices

12/25

Growth 2 Margin 4 Expansion 3 Platform 1 Financial 2

latest quarter score

Earnings Reports

12
CVRx (CVRX) Q2 2026: Sales Productivity Lag Drives Revenue Guide Cut Despite 87% Margin
August 07, 2026
15
CVRX (CVRX) Q4 2025: Category 1 CPT Code Unlocks 46% Medicare Advantage Approval, Setting Stage for Growth Acceleration
June 15, 2026
15
CVRX (CVRX) Q1 2026: U.S. Heart Failure Revenue Climbs 22% as Barostim Adoption Expands
May 12, 2026
14
CVRX (CVRX) Q3 2025: Gross Margin Rises 400bps as Barostim Adoption Deepens
November 06, 2025
12
CVRX (CVRX) Q2 2025: 35% New Sales Hires Drive Account Expansion, Reimbursement Tailwinds Build
August 04, 2025
13
CVRX (CVRX) Q1 2025: 25% Sales Team Overhaul Drives Transition, Productivity Ramp Key to H2 Recovery
July 05, 2025

Browse all companies